Merit Medical Systems Inc

MMSI

Equity

ISIN US5898891040 / Valor 951136

NASDAQ (2024-11-20)

USD 104.08-0.60%

Merit Medical Systems Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Merit Medical Systems Inc, established in 1987, is a prominent manufacturer and distributor of disposable medical devices utilized in various interventional, diagnostic, and therapeutic procedures, with a focus on cardiology, radiology, oncology, critical care, and endoscopy. The company caters to hospitals and physicians globally, boasting a workforce of around 7,000 employees.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Merit Medical Systems Inc. reported revenue of $338.0 million for the second quarter of 2024, marking an increase of 5.6% compared to the same period in 2023. On a constant currency basis, revenue grew by 6.6%, and organic constant currency revenue increased by 5.0% year-over-year.

Operating Margins

For the second quarter of 2024, Merit Medical Systems Inc. achieved a GAAP operating margin of 13.6%, up from 9.0% in the prior year period. The non-GAAP operating margin also improved, reaching 20.1% compared to 19.1% in the second quarter of 2023.

Earnings Per Share

Merit Medical Systems Inc. reported GAAP earnings per share (EPS) of $0.61 for the second quarter of 2024, a significant increase of 75.7% from the same quarter in 2023. Non-GAAP EPS was $0.92, up 16.8% year-over-year.

Segment Performance

In the second quarter of 2024, Merit Medical Systems Inc.'s Cardiovascular segment saw notable growth. Peripheral Intervention revenue increased by 10.6% to $139.2 million, while Cardiac Intervention revenue remained relatively flat at $93.9 million. The Endoscopy segment also performed well, with Endoscopy Devices revenue growing by 16.0% to $10.2 million.

Updated Financial Guidance

Merit Medical Systems Inc. has updated its financial guidance for the fiscal year ending December 31, 2024. The company now expects net sales to be between $1.335 billion and $1.345 billion, representing a 6% to 7% year-over-year increase. Non-GAAP earnings per share are projected to be in the range of $3.27 to $3.35, reflecting a 15% to 17% increase from the prior year.

Summarized from source with an LLMView Source

Key figures

44.9%1Y

50.3%3Y

285%5Y

Performance

25.0%1Y

29.8%3Y

37.3%5Y

Volatility